BPC-157
PeptideBody Protection Compound-157. A synthetic peptide derived from a protein found in gastric juice. Studied for tissue healing, gut repair, tendon regeneration, and neuroprotection.
Evidence comparisons not yet run for these claims.
Expert Consensus
Evidence Summary
The available evidence base for BPC-157 as an injectable therapeutic agent is extremely limited in the context of this review. Only a single review article was identified, described as moderate quality, with no specific population studied, no sample size reported, and no key findings or limitations documented. This makes it impossible to draw any meaningful conclusions about BPC-157's efficacy or safety in humans from the literature provided here. The sole article is a review piece exploring injectable therapeutic peptides broadly as a potential adjunct to regenerative medicine and sports performance. Because no primary data, clinical trial results, or quantitative findings were extracted from this source, there are no specific outcomes, effect sizes, or mechanistic insights that can be reported. The framing of the review as an open question — note the question mark in the title — suggests the field itself acknowledges the lack of definitive evidence rather than presenting established conclusions. Significant caution is warranted when evaluating claims about BPC-157. The overwhelming majority of research on this peptide exists in animal models (rodent studies), and robust human clinical trial data is largely absent from the published literature. Without randomized controlled trials, dose-response data in humans, or long-term safety studies, any claims about its benefits for injury recovery, tissue repair, or athletic performance remain speculative. Regulatory status is also a concern, as BPC-157 is not approved by major health agencies for human use. Anyone considering its use should be aware that the evidence simply does not yet support confident recommendations.
Read full evidence summary →Top studies
Injectable Therapeutic Peptides-An Adjunct to Regenerative Medicine and Sports Performance?
Injectable Therapeutic Peptides-An Adjunct to Regenerative Medicine and Sports Performance?
Expert Mentions
All 21 mentions
“again these are all pretty much experimental they've been shown to be effective in mice but still we have a long way to go before we know if they're truly effective in humans and they're there we always need placebo-controlled double-blind clinical studies which are underway”
BPC-157, like other peptides in this category, is largely experimental — shown to be effective in mice but not yet proven effective in humans, and still awaiting proper placebo-controlled double-blind clinical studies
“people with reflux it tightens the Lees Junction I have some people get off their reflux medicine that's the bottom of your esophagus where where the kind of reflux happens come back up from the stomach and there's not many things that tighten Lees Junction”
BPC-157 tightens the lower esophageal sphincter (LES junction), and the expert has had patients get off their reflux medication as a result.
Safety, interactions & who should avoid BPC-157
No safety data for BPC-157 in humans could be extracted from the single available review article. Given the absence of approved clinical use and the lack of human trial data, its safety profile in people is currently unknown.
BPC-157 has not been approved by the FDA for human use, and long-term safety data in humans is absent. It is classified as a research compound. Injectable forms carry risks of infection, improper dosing, and contamination — particularly when self-administered. The available review article is of moderate quality with no human population data reported.
Who should avoid it
Individuals with a personal or family history of cancer should exercise extreme caution given BPC-157's proposed pro-angiogenic properties. Pregnant or breastfeeding individuals, minors, and those with active infections or immune disorders should avoid use. Anyone considering use should consult a licensed physician, as human safety data is lacking.
Known interactions
- ·Potential interaction with anticoagulants or blood-thinning agents (theoretical, based on proposed angiogenic effects)
- ·Possible additive effects with other peptide hormones or growth factors — clinical significance unknown
Pregnancy & breastfeeding
Our sources specifically flag pregnancy or breastfeeding considerations for BPC-157 — see the cautions above.
We don’t assign pregnancy-safety ratings. Many supplements lack adequate safety data in pregnancy and breastfeeding, and the absence of a warning here does not mean a supplement is safe to take. Don’t start, stop, or continue any supplement while pregnant or nursing without your OB-GYN or midwife.
Read: Supplements during pregnancy & breastfeeding →This is educational information only. Consult a healthcare provider before starting any supplement.
Stay on top of BPC-157 research
One email a month when new research on BPC-157 is published.
Double opt-in · unsubscribe anytime · not medical advice.
No buy link — yet
We only link products that meet our sourcing standards. We haven’t linked one for BPC-157 yet. Our standards →
Key findings
- ·Only one review article was available for analysis, and it reported no extractable key findings.
- ·The review frames injectable therapeutic peptides as a potential adjunct to regenerative medicine and sports performance, but does not confirm efficacy.
- ·No human clinical populations, sample sizes, or outcome data were reported in the available literature.
Evidence gaps
- ·There are no human randomized controlled trials or controlled clinical studies on BPC-157 represented in this evidence base.
- ·No safety data, dosing protocols, or pharmacokinetic information in humans could be identified from the available study.
- ·The long-term effects of injectable BPC-157 in humans remain entirely unstudied based on this literature set.